Ariel E. Birnbaum

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Charu Aggarwal, Amy Prawira, Scott Antonia et al. · Journal for ImmunoTherapy of Cancer · 2022 · 141 citations · Full text

Life Sciences, Immunology, Oncology +17

Gastric Reflux Is an Independent Risk Factor for Laryngopharyngeal Carcinoma

Scott M. Langevin, Dominique S. Michaud, Carmen J. Marsit et al. · Cancer Epidemiology Biomarkers & Prevention · 2013 · 74 citations · Full text

Medicine, Oncology, Cancer Epidemiology +10

First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer

Aiwu Ruth He, Roger B. Cohen, Crystal S. Denlinger et al. · The Oncologist · 2019 · 61 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study

Jaroslaw T. Hepel, K.L. Leonard, Howard Safran et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 52 citations

Medicine, Oncology, Radiation Oncology +16

Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas

Kalyan Mantripragada, Ariel E. Birnbaum · Cureus · 2015 · 30 citations · Full text

Medicine, Immunology, Oncology +17